2023 Virtual Legislative Lobby Day

Join autoimmune patient advocates nationwide on March 29, 2023, for the National Coalition of Autoimmune Patient Groups’ first virtual Congressional Fly-in Day. Advocates will meet virtually with legislators and staff to discuss important issues, including improving patient access and research funding. Whether you’re a veteran advocate or looking to get involved in legislative advocacy for the first time, this is an incredible opportunity to make a difference for the autoimmune patient community.

We will be calling upon Congress to establish an Office of Autoimmunity within the Office of the Director of the National Institutes of Health. Read the letter we sent to the Senate and House Appropriations Committee encouraging them to include this in the FY2023 Appropriations bill.

REGISTER NOW

Frequently Asked Questions

What is a Lobby Day?

A fly-in or lobby day is when constituents from across the country come together to advocate to their congressional lawmakers on behalf of a common cause or interest.

Who should participate?
Autoimmune patients, care partners, family and friends, health care professionals, medical and scientific professionals, and anyone with an interest in and passion for changing the future of autoimmune disease is encouraged to participate and become an advocate.

Is there a cost to participate?

There is no cost to participate.

How will we meet with legislators and staff?

All virtual meetings will be conducted via Zoom or another video conference platform.

Do I need previous advocacy experience?

Definitely not! We will provide training and talking points.

How can I prepare?

Prior to the event, we will hold a training session with participants. The training session will help advocates better understand how to speak to elected leaders to get their point across and will use role-playing to demonstrate. Remember: a convincing and compelling case will gain more traction than a shouting match any day.

We will also provide talking points and key messages as guidance.